Cost-effectiveness Analysis of Four Kinds of Oral Hypoglycemic Drugs in Treating Diabetes / 中国药房
China Pharmacy
;
(12)1991.
Article
Dans Chinois
| WPRIM
| ID: wpr-521967
ABSTRACT
OBJECTIVE:
To select a best therapeutic scheme for diabetes among four kinds of oral hypoglycemic drugsrepaglinide(Novonorm),glibenclamide,gliclazide and glipizide.METHODS:
According to the principle of pharmacoeconomics,using cost-effectiveness analysis(CEA),assessment and survey of the influencing factors(price,dosage)were carried out,at the same time,sensitive analysis was performed.RESULTS:
The best therapeutic scheme was Novonorm and the rest were gliclazide,glipizide and glibenclamide in sequence.CONCLUSION:
The result of sensitive analysis is in keeping with that of CEA,which indicates the credibility of CEA.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Évaluation en économique de la santé
langue:
Chinois
Texte intégral:
China Pharmacy
Année:
1991
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS